Skip to main content

Trump Plans Campaign Rally in Minnesota

President Donald Trump will visit Minnesota for a reelection rally in October.

As impeachment talk swirled in Washington over Trump’s handling of a call with Ukraine’s president, his campaign announced Thursday that Trump will host a rally Oct. 10 at Target Center in Minneapolis.

The president lost Minnesota to Hillary Clinton by just 1.5 percentage points in 2016, and he has frequently talked of his desire to win it in 2020. He’s made several visits to the state.

Trump’s success in breaking the Democrats’ so-called blue wall in Wisconsin, Michigan and Pennsylvania was key to him winning the White House.

More must-read stories from Fortune:

A running list of questions on the impeachment inquiry, answered
5 allegations made in the declassified whistleblower complaint
What is CrowdStrike? Trump mentioned the company in his Ukraine call
—These are the key players in the Trump impeachment inquiry
—How impeachment momentum massively shifted among democrats
—The 25 most powerful women in politics
Follow Fortune on Flipboard to stay up-to-date on the latest news and analysis.



from Fortune https://ift.tt/2majtTH

Comments

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be